Opportunity Information: Apply for RFA AG 22 003

The NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award is an NIH-funded training grant opportunity (R25; clinical trial not allowed) run by the National Institute on Aging (NIA). Its core purpose is to support the creation or expansion of structured entrepreneurship training programs that help researchers build practical, market-aware skills alongside their scientific expertise. The emphasis is on areas that align with NIA's mission, especially aging research and Alzheimer's disease (AD) and related dementias. Rather than funding a traditional research project or a clinical study, this program is aimed at workforce development: it is meant to immerse trainees in entrepreneurial thinking and translational pathways so they can pursue a broader range of careers, including roles outside the standard academic research track.

The target participants are graduate students and postdoctoral researchers, as well as early-career scientists holding masters, Ph.D., or Dr.P.H. degrees. The intent is to broaden their professional skillsets in ways that make them more effective at moving ideas from the lab toward real-world impact, whether that ends up being through startups, industry R&D, technology transfer offices, nonprofits, government, or other innovation-oriented settings. In practical terms, the supported programs would typically focus on skills like identifying unmet needs in aging and AD, evaluating commercial potential, understanding regulatory and reimbursement considerations, building product development roadmaps, intellectual property basics, customer discovery, partnerships, and communicating science to non-academic stakeholders. The overall goal is to produce scientists who can navigate both the scientific and the commercialization/implementation sides of innovation.

Eligibility is broad and includes many types of U.S.-based organizations. Eligible applicants listed in the source include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations (including those other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. At the same time, it places clear geographic restrictions: non-U.S. (foreign) institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them in its Grants Policy Statement) are not allowed.

From the administrative details provided, this is a discretionary grant opportunity in the health category with CFDA number 93.866, issued by the National Institutes of Health. The funding opportunity title is "NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed)" and the funding opportunity number is RFA-AG-22-003. The original closing date listed is October 4, 2021, and the opportunity record shows a creation date of June 10, 2021. No award ceiling amount or expected number of awards is specified in the provided source text, so applicants would normally need to consult the full funding announcement for budget limits, project period details, and any special NIA program requirements.

In short, this NIA REDI R25 opportunity is designed to fund entrepreneurship-focused training programs that prepare early-career researchers in aging and Alzheimer's-related fields to translate discoveries into real-world solutions and to pursue diverse, innovation-oriented career paths, while explicitly excluding clinical trials and disallowing foreign applicants or foreign components.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2021-06-10.
  • Applicants must submit their applications by 2021-10-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 22 003

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Entrepreneurs

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Limited Competition: Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Previous opportunity: NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 22 003

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 22 003) also looked into and applied for these:

Funding Opportunity
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) Apply for PAR 21 240

Funding Number: PAR 21 240
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 21 243

Funding Number: PAR 21 243
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) Apply for PAR 21 242

Funding Number: PAR 21 242
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) Apply for PAR 21 241

Funding Number: PAR 21 241
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 22 017

Funding Number: RFA AG 22 017
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 018

Funding Number: RFA AG 22 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Disaster Risk Management Apply for 720 663 21 RFI 00007

Funding Number: 720 663 21 RFI 00007
Agency: Ethiopia USAID-Addis Ababa
Category: Health
Funding Amount: $8,000,000
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional) Apply for PAR 21 250

Funding Number: PAR 21 250
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) Apply for PAR 21 249

Funding Number: PAR 21 249
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required) Apply for RFA MH 21 241

Funding Number: RFA MH 21 241
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) Apply for RFA DC 22 001

Funding Number: RFA DC 22 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed) Apply for PAR 21 269

Funding Number: PAR 21 269
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required) Apply for RFA MH 21 240

Funding Number: RFA MH 21 240
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) Apply for PAR 21 204

Funding Number: PAR 21 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional) Apply for RFA HG 21 025

Funding Number: RFA HG 21 025
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 22 027

Funding Number: RFA AG 22 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) Apply for RFA AG 22 022

Funding Number: RFA AG 22 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 21 263

Funding Number: PAR 21 263
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 21 264

Funding Number: PAR 21 264
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) Apply for RFA HG 21 001

Funding Number: RFA HG 21 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 22 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: